OV
Therapeutic Areas
Evariste Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PKMYT1 Inhibitor (EVT-3023) | NSCLC, CRC, OC | Preclinical |
| VRK1 Inhibitor | Glioblastoma (GBM), Neuroblastoma | Early Discovery |
| Novel SL Target Inhibitor | AML, DLBCL, HR-deficient solid tumors | Early Discovery |